Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Longeveron Inc (LGVNR)

Longeveron Inc (LGVNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 +400.00%
on 09/21/23
0.2058 -99.76%
on 08/22/23
-0.2490 (-99.80%)
since 08/21/23

Most Recent Stories

More News
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update

LGVN : 2.30 (+5.99%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)

LGVN : 2.30 (+5.99%)
LGVNR : 0.0005 (-37.50%)
Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

LGVN : 2.30 (+5.99%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)

LGVN : 2.30 (+5.99%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting

LGVN : 2.30 (+5.99%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)

LGVN : 2.30 (+5.99%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting

LGVN : 2.30 (+5.99%)
LGVNR : 0.0005 (-37.50%)
Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day

LGVN : 2.30 (+5.99%)
LGVNR : 0.0005 (-37.50%)
Longeveron (NASDAQ: LGVN; LGVNR) Study Survival Data Reported at AHA’s Scientific Sessions

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS),...

LGVNR : 0.0005 (-37.50%)
LGVN : 2.30 (+5.99%)
Longeveron (NASDAQ: LGVN; LGVNR) Announces Plans to Release Q3 2023 Financial Report

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, has announced plans to report its financial results...

LGVNR : 0.0005 (-37.50%)
LGVN : 2.30 (+5.99%)

Key Turning Points

3rd Resistance Point 0.0025
2nd Resistance Point 0.0020
1st Resistance Point 0.0012
Last Price 0.0005
1st Support Level N/A
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 2.0500
Fibonacci 61.8% 1.2669
Fibonacci 50% 1.0250
Fibonacci 38.2% 0.7832
Last Price 0.0005
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar